ISDA

Deposition Date 2005-12-13

Release Date 2006-02-21

Last Version Date 2024-02-14

Entry Detail

PDB ID:

2FDD

Keywords:

HYDROLASE

Title:

Crystal structure of HIV protease D545701 bound with GW0385

Biological Source:

Source Organism:

Human immunodeficiency virus 1 (Taxon ID: 11676)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.58 Å

R-Value Free:

0.23

R-Value Work:

0.21

R-Value Observed:

0.21

Space Group:

P 41

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Gag-Pol polyprotein
Mutations:L10I L19Q K20R E35D M36I S37N M46I I50V I54V I62V L63P A71V V82A L90M
Chain IDs:A, B
Chain Length:100
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1

UniProt ID:Q7SPG9 Pfam ID:PF00077

Ligand Molecules

385

Primary Citation

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385.

Miller, J.F, Andrews, C.W, Brieger, M, Furfine, E.S, Hale, M.R, Hanlon, M.H, Hazen, R.J, Kaldor, I, McLean, E.W, Reynolds, D, Sammond, D.M, Spaltenstein, A, Tung, R, Turner, E.M, Xu, R.X, Sherrill, R.G.Show

Bioorg.Med.Chem.Lett. 16 1788 1794 (2006)

PMID: 16458505 DOI: 10.1016/j.bmcl.2006.01.035

Abstact

A novel series of P1 modified HIV protease inhibitors was synthesized and evaluated for in vitro antiviral activity against wild-type virus and protease inhibitor-resistant viruses. Optimization of the P1 moiety resulted in compounds with femtomolar enzyme activities and cellular antiviral activities in the low nanomolar range culminating in the identification of clinical candidate GW0385.

Legend

Protein

Chemical

Disease

Primary Citation of related structures